{"id":958812,"date":"2026-05-06T07:34:08","date_gmt":"2026-05-06T11:34:08","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-to-present-at-may-investor-conferences\/"},"modified":"2026-05-06T07:34:08","modified_gmt":"2026-05-06T11:34:08","slug":"crescent-biopharma-to-present-at-may-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-to-present-at-may-investor-conferences\/","title":{"rendered":"Crescent Biopharma to Present at May Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">WALTHAM, Mass., May  06, 2026  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=jk1RTPpEMJA3fH1zkFbaiBCaJEoFvoyFBUd9dT6WTZBG0VHDFZ2Sxw7LDyU89bDU-9t8PcHzZ1023_JLFrtuqinKbrCKOUis7-izjhv_w0RHLWoaUCeTycBZaz93QjZn\" rel=\"nofollow\" target=\"_blank\">Crescent Biopharma, Inc.<\/a> (\u201cCrescent\u201d or the \u201cCompany\u201d) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that management is scheduled to present at the following investor conferences in May:<\/p>\n<ul type=\"disc\">\n<li style=\"margin-top:5pt;margin-bottom:5pt\">\n          <strong>BofA Securities 2026 Healthcare Conference, <\/strong>fireside chat on Wednesday, May 13, 2026 at 4:20 p.m. PT (7:20 p.m. ET) in Las Vegas<\/li>\n<li>\n          <strong>2026 Stifel Virtual Targeted Oncology Forum, <\/strong>virtual fireside chat on Wednesday, May 20, 2026 at 2:30 p.m. ET<\/li>\n<li>\n          <strong>TD Cowen 7<\/strong><br \/>\n          <sup><br \/>\n            <strong>th<\/strong><br \/>\n          <\/sup><br \/>\n          <strong> Annual Oncology Innovation Summit: Insights for ASCO &amp; EHA, <\/strong>virtual fireside chat on Tuesday, May 26, 2026 at 11:30 a.m. ET<\/p>\n<\/li>\n<\/ul>\n<p>A live webcast of each presentation will be available in the Investors section of Crescent&#8217;s website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=24ni26UJx9yp8t7EYvKNfXSfGzTxni4I3PjsWh613dCXHUNyNKpJ6HEauHKVbOX8xeGZ1uq0eld3DT8x_bJMKPP1XwAQ9R9mddsZnwN3X_OBIxh-Rmt_AN3x9HZCiEIxUIWB8X8Je983PHdtcYUtGE3rmlEFbRHaIKZGKaNdvoTTomO-rd1PHNNX7YOcb_SPabb35TcQPtqybQhFIPCZbqgvzM2z7LXDxO38tzZ5_OOPeOeqZaYC4d_P2jdmPo-2n7uCWfTNWN4bEDpY6fxTSttoh-uyDNRegZA7ryclbS5_J0o0CoMB7M7tekLMBne6WR3avX7AidCeyW66tsp6_EmNTJBM2eevKATQ5_XEwtZxKdy6GrLf406_jTUWnupSG_LipiPmAVOy38Il0-jB8OSiTVpIgmGqzlvEUOklyXGd1GPJ8ooJ3_N-MnOUnjSTtUT9tkJXDCPBB47dtIG32g==\" rel=\"nofollow\" target=\"_blank\">https:\/\/investors.crescentbiopharma.com\/events-presentations<\/a>, and a replay will be accessible for 90 days.<\/p>\n<p><strong>About Crescent Biopharma<\/strong><\/p>\n<p>Crescent Biopharma\u2019s vision is to build a world leading oncology company bringing the next wave of therapies for cancer patients. The Company\u2019s clinical-stage pipeline includes its lead program, a PD-1 x VEGF bispecific antibody, as well as novel antibody-drug conjugates (ADCs). By leveraging multiple modalities and established targets, Crescent aims to rapidly advance potentially transformative therapies either as single agents or as part of combination regimens to treat a range of solid tumors. For more information, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Am4pPDoVSsBLnWV9KCoKhf8GDUedT9d3dpO8GhcGskDQySStp99C9dUaEDNMa5y4K1cveFs5ZqLzqgO4tW6gU3gGaROXtI6Mu9GpePz-BB-XXPo3fvqvaouviELbO4EJq5Q6RqrU0I89xHpmFgRa1-Ci2OtpxEzEqiBb91js-0xED6JLuxM5Q3_v600s1-2SxpL3eNt7xbQP9E2QTTdbYEdG0FEvRx02ysjX1b3D30klFuHL0VCMPiqgxWd2eJf33h2J22aCHGnatb-3faF4GKj_vegoT7PtB0Uoso8SnfA=\" rel=\"nofollow\" target=\"_blank\">www.crescentbiopharma.com<\/a>\u00a0and follow the Company on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=tPVjq5WaTlLmAuFgWmUvnRkZCAE2oto0d4PsFQaMVax7Cruuq369WwhPVDhu7aWgsypBXTM--xbZN87FOCZPcNd8DGy57AWXGDmLeuJ-uxt_ZAwzMyASIo6WjqDIXrqKCiNlFEQoqsOxscL4ICbbc7s_IV7hd7FRyG0tPiN_TcoZMIItIcCwG8Zi5U5QOy_qQ5tPnvd-4G-0DJf2LdS7flSl5V_WNva-haas5aJ_HCaLIZgGJ3fPJEOKV43XLpmq2CgiosbWToGN7xbBZpHzLDPUT7MPHGPjENjgbJ093nNuAdoNJpYUWxzjZwf_2c3WzLZt5WhJEQAGmmsMtL6CSsrxtytS3FBpPQDUCJ44hM38ehM0bTHcWmhX3zKvPOHMO2eh9MIUTf-kTUy1x7ENWRvG3cW0kLaDI-pxuy8PVkIJgfNDbFuPOHunHsLYV0fa9fS6UquTOahvUU0hdXUcVdqupJHYJ5-mpcxNZcRwKBE=\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>\u00a0and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=IkxHcygEVNWNDB9hfKUsNfUP2Efy3nsDHzGoreJb1vgxa3b7-PLUGVSByPLyERa5gfXMXjf0kmuDLZo7MrDq03R0z2nAjpARUKtNJe4zd-y6JRlT0Pi1oNadufgV-Cj5NJFSh9AKcKDwJy3iJg70wVZLdLUcoIdzolxDWAGjzOsrHswu1ljUFQjTtTo_xo5cwi0DUuOEoLX4OupfPHVjKx9J7vV8HRgH1OAbpfcOvzUB8an9UJE_B7O1DEKrUwMywjvEyYRXXDQj6lV_sfKHXkHkfxy_cviKsxxoKw0opzIZuDMNmEmvJxC2poCHd1YIkqNTIwqwnWsWf1fIocRKEcXgkXJRoy3bbvTq5sUUF4SeDV4plBwdi0xj7DOJGfC1\" rel=\"nofollow\" target=\"_blank\">X<\/a>.<\/p>\n<p>\n        <strong>Contacts<\/strong><\/p>\n<p>        <strong>Investors<\/strong><br \/>\n        <br \/>Amy Reilly<br \/>Chief Communications Officer<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=kAR1wwpJW5nvvL6vfL1tG2CWa8rHIwXbqKQ9vEbL5nXbRoPiSUeUsRhJNbAN_R_qMN2Pmq-16uKNzVcBvsammTc_8juCAMBNv-LkGkwA0B8UwU9UIjTVXGlXCHBlGHxSha1CPIuEY-G6th_KkXyWsg==\" rel=\"nofollow\" target=\"_blank\">amy.reilly@crescentbiopharma.com<\/a><br \/>617-465-0586<\/p>\n<p>\n        <strong>Media<\/strong><br \/>\n        <br \/>Jenna Poist<br \/>Director, Corporate Communications<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=JFckvjtdAJ3lLMNYHhXOWkgOAQIxZA1UB-00Yi0l-acjiP4jTJF2Jzy3YZF0K6qPT-N3ZBqKF2AqS6ZAUzrWrMDyhbR-e1ic7x4k79HOLKW3a-9rGVNMxy-44sLhyYMplgSV5RAf8XKmIKp0k75uCQ==\" rel=\"nofollow\" target=\"_blank\">jenna.poist@crescentbiopharma.com<\/a><br \/>781-671-5019<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxNDAwNiM3NTgxNTI0IzIyOTg0ODA=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NTg3Yzk4ZTItZjkwMC00ODdkLWFlYTItNTgxMjAxMTM5OTkwLTEzMTAwMzAtMjAyNi0wNS0wNi1lbg==\/tiny\/Crescent-Biopharma-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>WALTHAM, Mass., May 06, 2026 (GLOBE NEWSWIRE) &#8212; Crescent Biopharma, Inc. (\u201cCrescent\u201d or the \u201cCompany\u201d) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that management is scheduled to present at the following investor conferences in May: BofA Securities 2026 Healthcare Conference, fireside chat on Wednesday, May 13, 2026 at 4:20 p.m. PT (7:20 p.m. ET) in Las Vegas 2026 Stifel Virtual Targeted Oncology Forum, virtual fireside chat on Wednesday, May 20, 2026 at 2:30 p.m. ET TD Cowen 7 th Annual Oncology Innovation Summit: Insights for ASCO &amp; EHA, virtual fireside chat on Tuesday, May 26, 2026 at 11:30 a.m. ET A live webcast of each presentation will &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-to-present-at-may-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Crescent Biopharma to Present at May Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-958812","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Crescent Biopharma to Present at May Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-to-present-at-may-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Crescent Biopharma to Present at May Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"WALTHAM, Mass., May 06, 2026 (GLOBE NEWSWIRE) &#8212; Crescent Biopharma, Inc. (\u201cCrescent\u201d or the \u201cCompany\u201d) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that management is scheduled to present at the following investor conferences in May: BofA Securities 2026 Healthcare Conference, fireside chat on Wednesday, May 13, 2026 at 4:20 p.m. PT (7:20 p.m. ET) in Las Vegas 2026 Stifel Virtual Targeted Oncology Forum, virtual fireside chat on Wednesday, May 20, 2026 at 2:30 p.m. ET TD Cowen 7 th Annual Oncology Innovation Summit: Insights for ASCO &amp; EHA, virtual fireside chat on Tuesday, May 26, 2026 at 11:30 a.m. ET A live webcast of each presentation will &hellip; Continue reading &quot;Crescent Biopharma to Present at May Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-to-present-at-may-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-06T11:34:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxNDAwNiM3NTgxNTI0IzIyOTg0ODA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crescent-biopharma-to-present-at-may-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crescent-biopharma-to-present-at-may-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Crescent Biopharma to Present at May Investor Conferences\",\"datePublished\":\"2026-05-06T11:34:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crescent-biopharma-to-present-at-may-investor-conferences\\\/\"},\"wordCount\":256,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crescent-biopharma-to-present-at-may-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxNDAwNiM3NTgxNTI0IzIyOTg0ODA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crescent-biopharma-to-present-at-may-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crescent-biopharma-to-present-at-may-investor-conferences\\\/\",\"name\":\"Crescent Biopharma to Present at May Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crescent-biopharma-to-present-at-may-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crescent-biopharma-to-present-at-may-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxNDAwNiM3NTgxNTI0IzIyOTg0ODA=\",\"datePublished\":\"2026-05-06T11:34:08+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crescent-biopharma-to-present-at-may-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crescent-biopharma-to-present-at-may-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crescent-biopharma-to-present-at-may-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxNDAwNiM3NTgxNTI0IzIyOTg0ODA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxNDAwNiM3NTgxNTI0IzIyOTg0ODA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crescent-biopharma-to-present-at-may-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Crescent Biopharma to Present at May Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Crescent Biopharma to Present at May Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-to-present-at-may-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Crescent Biopharma to Present at May Investor Conferences - Market Newsdesk","og_description":"WALTHAM, Mass., May 06, 2026 (GLOBE NEWSWIRE) &#8212; Crescent Biopharma, Inc. (\u201cCrescent\u201d or the \u201cCompany\u201d) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that management is scheduled to present at the following investor conferences in May: BofA Securities 2026 Healthcare Conference, fireside chat on Wednesday, May 13, 2026 at 4:20 p.m. PT (7:20 p.m. ET) in Las Vegas 2026 Stifel Virtual Targeted Oncology Forum, virtual fireside chat on Wednesday, May 20, 2026 at 2:30 p.m. ET TD Cowen 7 th Annual Oncology Innovation Summit: Insights for ASCO &amp; EHA, virtual fireside chat on Tuesday, May 26, 2026 at 11:30 a.m. ET A live webcast of each presentation will &hellip; Continue reading \"Crescent Biopharma to Present at May Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-to-present-at-may-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2026-05-06T11:34:08+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxNDAwNiM3NTgxNTI0IzIyOTg0ODA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-to-present-at-may-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-to-present-at-may-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Crescent Biopharma to Present at May Investor Conferences","datePublished":"2026-05-06T11:34:08+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-to-present-at-may-investor-conferences\/"},"wordCount":256,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-to-present-at-may-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxNDAwNiM3NTgxNTI0IzIyOTg0ODA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-to-present-at-may-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-to-present-at-may-investor-conferences\/","name":"Crescent Biopharma to Present at May Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-to-present-at-may-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-to-present-at-may-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxNDAwNiM3NTgxNTI0IzIyOTg0ODA=","datePublished":"2026-05-06T11:34:08+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-to-present-at-may-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-to-present-at-may-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-to-present-at-may-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxNDAwNiM3NTgxNTI0IzIyOTg0ODA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxNDAwNiM3NTgxNTI0IzIyOTg0ODA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-to-present-at-may-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Crescent Biopharma to Present at May Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/958812","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=958812"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/958812\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=958812"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=958812"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=958812"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}